This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-107 | ABCA6 | -0.07 | 0.96422 | -0.01 | 0.97622 | miRanda | -0.78 | 0.00096 | NA | |
2 | hsa-miR-107 | ABI2 | -0.07 | 0.96422 | -0.12 | 0.8703 | miRanda | -0.12 | 0.02139 | NA | |
3 | hsa-miR-107 | ABI3BP | -0.07 | 0.96422 | -0.37 | 0.41633 | miRanda | -0.77 | 0.00053 | NA | |
4 | hsa-miR-338-3p | ABI3BP | 0.26 | 0.82352 | -0.37 | 0.41633 | miRanda | -0.34 | 0.00054 | NA | |
5 | hsa-miR-107 | ABL2 | -0.07 | 0.96422 | 0.04 | 0.95748 | MirTarget; PITA; miRanda; miRNATAP | -0.15 | 0.0065 | NA | |
6 | hsa-miR-107 | ACACB | -0.07 | 0.96422 | -0.08 | 0.89068 | miRanda | -0.41 | 0.00057 | NA | |
7 | hsa-miR-107 | ACTG2 | -0.07 | 0.96422 | -0.09 | 0.92216 | miRanda | -1.78 | 0 | NA | |
8 | hsa-miR-107 | ACVR1 | -0.07 | 0.96422 | -0.02 | 0.98204 | miRanda | -0.11 | 0.02024 | NA | |
9 | hsa-miR-107 | ACVR2B | -0.07 | 0.96422 | -0.2 | 0.71234 | PITA; miRNATAP | -0.24 | 0.00172 | NA | |
10 | hsa-miR-338-3p | ADAM11 | 0.26 | 0.82352 | 0.11 | 0.80369 | mirMAP | -0.2 | 0.01167 | NA | |
11 | hsa-miR-107 | ADAMTS1 | -0.07 | 0.96422 | 0.03 | 0.96886 | miRanda | -0.37 | 0.00449 | NA | |
12 | hsa-miR-338-3p | ADAMTS1 | 0.26 | 0.82352 | 0.03 | 0.96886 | miRanda | -0.13 | 0.01943 | NA | |
13 | hsa-miR-107 | ADAMTS19 | -0.07 | 0.96422 | 1.17 | 0.10747 | miRanda | -0.83 | 0.00455 | NA | |
14 | hsa-miR-107 | ADAMTS3 | -0.07 | 0.96422 | -0.15 | 0.57772 | miRanda | -0.46 | 0.00107 | NA | |
15 | hsa-miR-338-3p | ADAMTS6 | 0.26 | 0.82352 | 0.02 | 0.94873 | miRNATAP | -0.16 | 0.01117 | NA | |
16 | hsa-miR-107 | ADAMTSL1 | -0.07 | 0.96422 | -0.22 | 0.5533 | miRanda | -0.56 | 0.00121 | NA | |
17 | hsa-miR-107 | ADAMTSL3 | -0.07 | 0.96422 | -0.2 | 0.64161 | MirTarget; PITA; miRanda; miRNATAP | -1.21 | 0 | NA | |
18 | hsa-miR-107 | ADCY4 | -0.07 | 0.96422 | 0.26 | 0.45422 | miRanda | -0.33 | 0.00187 | NA | |
19 | hsa-miR-107 | ADCYAP1 | -0.07 | 0.96422 | 0.13 | 0.79662 | MirTarget; PITA; miRanda; miRNATAP | -1.29 | 0 | NA | |
20 | hsa-miR-107 | ADD2 | -0.07 | 0.96422 | -0.16 | 0.76694 | miRNAWalker2 validate; miRNATAP | -0.98 | 5.0E-5 | NA | |
21 | hsa-miR-107 | ADNP | -0.07 | 0.96422 | -0.13 | 0.89598 | miRanda | -0.14 | 0.02172 | NA | |
22 | hsa-miR-107 | ADRB2 | -0.07 | 0.96422 | -0.01 | 0.98489 | miRanda | -0.43 | 0.01913 | NA | |
23 | hsa-miR-338-3p | ADRB2 | 0.26 | 0.82352 | -0.01 | 0.98489 | miRanda | -0.23 | 0.0054 | NA | |
24 | hsa-miR-338-3p | AIF1L | 0.26 | 0.82352 | 0.17 | 0.69229 | miRanda | -0.15 | 0.0389 | NA | |
25 | hsa-miR-107 | AKAP12 | -0.07 | 0.96422 | 0.17 | 0.82172 | miRanda; miRNATAP | -0.91 | 1.0E-5 | NA | |
26 | hsa-miR-338-3p | AKAP12 | 0.26 | 0.82352 | 0.17 | 0.82172 | miRanda | -0.26 | 0.00378 | NA | |
27 | hsa-miR-107 | AKAP2 | -0.07 | 0.96422 | 0.07 | 0.92 | MirTarget; PITA; miRanda; miRNATAP | -0.32 | 0.00722 | NA | |
28 | hsa-miR-107 | AKAP6 | -0.07 | 0.96422 | -0.07 | 0.82446 | miRanda | -0.64 | 0 | NA | |
29 | hsa-miR-107 | AKT3 | -0.07 | 0.96422 | 0.06 | 0.90908 | PITA; miRanda | -0.55 | 0.00017 | NA | |
30 | hsa-miR-107 | ALDH1B1 | -0.07 | 0.96422 | 0.09 | 0.93378 | miRanda | -0.32 | 0.00056 | NA | |
31 | hsa-miR-107 | ALPK3 | -0.07 | 0.96422 | 0.84 | 0.17219 | mirMAP | -0.52 | 0.0174 | NA | |
32 | hsa-miR-338-3p | AMACR | 0.26 | 0.82352 | 0.02 | 0.98492 | miRanda | -0.15 | 0.01357 | NA | |
33 | hsa-miR-107 | AMPH | -0.07 | 0.96422 | 0.08 | 0.81124 | miRanda | -0.57 | 0.00193 | NA | |
34 | hsa-miR-107 | AMT | -0.07 | 0.96422 | 0.09 | 0.87288 | miRanda | -0.46 | 0.02226 | NA | |
35 | hsa-miR-107 | ANGPTL7 | -0.07 | 0.96422 | -0.01 | 0.99351 | miRanda | -1.49 | 0 | NA | |
36 | hsa-miR-338-3p | ANGPTL7 | 0.26 | 0.82352 | -0.01 | 0.99351 | miRanda | -0.24 | 0.03118 | NA | |
37 | hsa-miR-107 | ANKRD6 | -0.07 | 0.96422 | 0.22 | 0.43754 | miRanda | -0.49 | 0.00034 | NA | |
38 | hsa-miR-107 | ANTXR1 | -0.07 | 0.96422 | -0.05 | 0.96265 | miRanda | -0.6 | 0.00138 | NA | |
39 | hsa-miR-107 | AP1S2 | -0.07 | 0.96422 | 0.12 | 0.80192 | PITA; miRanda | -0.21 | 0.02448 | NA | |
40 | hsa-miR-338-3p | AP1S2 | 0.26 | 0.82352 | 0.12 | 0.80192 | MirTarget; PITA; miRanda | -0.12 | 0.00569 | NA | |
41 | hsa-miR-107 | AP3B2 | -0.07 | 0.96422 | 0.36 | 0.54833 | miRanda | -1.1 | 4.0E-5 | NA | |
42 | hsa-miR-107 | APBA1 | -0.07 | 0.96422 | -0.19 | 0.64004 | miRNATAP | -0.31 | 0.01764 | NA | |
43 | hsa-miR-338-3p | APOLD1 | 0.26 | 0.82352 | 0.35 | 0.649 | miRanda | -0.18 | 0.02782 | NA | |
44 | hsa-miR-107 | ARHGAP1 | -0.07 | 0.96422 | 0.03 | 0.97401 | miRanda | -0.13 | 0.00718 | NA | |
45 | hsa-miR-107 | ARHGAP20 | -0.07 | 0.96422 | 0.1 | 0.77766 | miRanda | -0.53 | 0.00541 | NA | |
46 | hsa-miR-107 | ARHGAP24 | -0.07 | 0.96422 | -0.03 | 0.93164 | miRanda | -0.44 | 0.00038 | NA | |
47 | hsa-miR-338-3p | ARHGAP6 | 0.26 | 0.82352 | -0.42 | 0.35366 | miRanda | -0.26 | 0.00512 | NA | |
48 | hsa-miR-107 | ARMCX2 | -0.07 | 0.96422 | 0.29 | 0.5542 | miRanda; miRNATAP | -0.8 | 0 | NA | |
49 | hsa-miR-107 | ARMCX3 | -0.07 | 0.96422 | 0.03 | 0.9666 | miRanda | -0.23 | 0.02634 | NA | |
50 | hsa-miR-338-3p | ARMCX3 | 0.26 | 0.82352 | 0.03 | 0.9666 | MirTarget; PITA; miRanda | -0.14 | 0.00164 | NA | |
51 | hsa-miR-338-3p | ARSB | 0.26 | 0.82352 | -0.08 | 0.88514 | miRanda | -0.16 | 2.0E-5 | NA | |
52 | hsa-miR-107 | ATL1 | -0.07 | 0.96422 | 0.03 | 0.93523 | miRanda | -0.29 | 0.00538 | NA | |
53 | hsa-miR-338-3p | ATL1 | 0.26 | 0.82352 | 0.03 | 0.93523 | miRanda | -0.14 | 0.00195 | NA | |
54 | hsa-miR-338-3p | ATP10D | 0.26 | 0.82352 | -0.06 | 0.91566 | MirTarget; miRanda | -0.11 | 0.01855 | NA | |
55 | hsa-miR-107 | ATP1B2 | -0.07 | 0.96422 | -0.1 | 0.73974 | miRanda; miRNATAP | -0.86 | 0 | NA | |
56 | hsa-miR-107 | ATP2B4 | -0.07 | 0.96422 | -0.13 | 0.8766 | miRanda | -0.4 | 0.0005 | NA | |
57 | hsa-miR-338-3p | ATRN | 0.26 | 0.82352 | -0.46 | 0.56279 | MirTarget; miRanda | -0.17 | 0.00015 | NA | |
58 | hsa-miR-107 | ATRNL1 | -0.07 | 0.96422 | -0.45 | 0.38984 | miRanda | -1.39 | 0 | NA | |
59 | hsa-miR-107 | ATXN1 | -0.07 | 0.96422 | -0.02 | 0.9752 | PITA; miRanda | -0.18 | 0.00973 | NA | |
60 | hsa-miR-107 | BACE1 | -0.07 | 0.96422 | -0.16 | 0.82465 | miRNAWalker2 validate; miRTarBase | -0.26 | 0.0028 | NA | |
61 | hsa-miR-107 | BACH2 | -0.07 | 0.96422 | -0.35 | 0.26727 | MirTarget; PITA; miRNATAP | -0.59 | 0.00091 | NA | |
62 | hsa-miR-107 | BASP1 | -0.07 | 0.96422 | 0.06 | 0.91132 | miRanda | -0.32 | 0.03293 | NA | |
63 | hsa-miR-107 | BBS9 | -0.07 | 0.96422 | -0.3 | 0.50207 | miRanda | -0.18 | 0.00884 | NA | |
64 | hsa-miR-107 | BCL11A | -0.07 | 0.96422 | -0.11 | 0.85575 | PITA; miRanda; miRNATAP | -0.46 | 0.00496 | NA | |
65 | hsa-miR-338-3p | BCL11A | 0.26 | 0.82352 | -0.11 | 0.85575 | miRanda | -0.22 | 0.00271 | NA | |
66 | hsa-miR-107 | BCL2L2 | -0.07 | 0.96422 | 0 | 0.99812 | miRNATAP | -0.13 | 0.01217 | NA | |
67 | hsa-miR-107 | BMX | -0.07 | 0.96422 | -0.01 | 0.97533 | MirTarget; miRanda; miRNATAP | -0.63 | 0.00422 | NA | |
68 | hsa-miR-338-3p | BMX | 0.26 | 0.82352 | -0.01 | 0.97533 | miRanda | -0.26 | 0.0089 | NA | |
69 | hsa-miR-107 | BNIP3 | -0.07 | 0.96422 | 0.24 | 0.69186 | miRanda | -0.41 | 0.04607 | NA | |
70 | hsa-miR-338-3p | BOC | 0.26 | 0.82352 | -0.09 | 0.87023 | miRanda | -0.27 | 0.00091 | NA | |
71 | hsa-miR-338-3p | BST1 | 0.26 | 0.82352 | 0.23 | 0.52012 | miRanda | -0.15 | 0.03629 | NA | |
72 | hsa-miR-107 | BTG2 | -0.07 | 0.96422 | 0.01 | 0.99517 | MirTarget; PITA; miRanda; miRNATAP | -0.24 | 0.0064 | NA | |
73 | hsa-miR-338-3p | BTN2A2 | 0.26 | 0.82352 | 0.1 | 0.83527 | miRanda | -0.1 | 0.00614 | NA | |
74 | hsa-miR-338-3p | BVES | 0.26 | 0.82352 | 0.04 | 0.90028 | miRanda | -0.29 | 3.0E-5 | NA | |
75 | hsa-miR-107 | C17orf51 | -0.07 | 0.96422 | -0.1 | 0.83489 | mirMAP | -0.29 | 0.00377 | NA | |
76 | hsa-miR-107 | CACNA1B | -0.07 | 0.96422 | -0.19 | 0.77523 | miRanda | -1.29 | 0 | NA | |
77 | hsa-miR-107 | CACNA1C | -0.07 | 0.96422 | -0.15 | 0.80484 | miRNATAP | -0.64 | 5.0E-5 | NA | |
78 | hsa-miR-107 | CACNA2D1 | -0.07 | 0.96422 | -0.25 | 0.60439 | PITA; miRanda; miRNATAP | -1.17 | 1.0E-5 | NA | |
79 | hsa-miR-338-3p | CACNA2D1 | 0.26 | 0.82352 | -0.25 | 0.60439 | miRanda | -0.36 | 0.00235 | NA | |
80 | hsa-miR-107 | CACNB4 | -0.07 | 0.96422 | 0.17 | 0.63328 | miRanda | -0.42 | 0.02147 | NA | |
81 | hsa-miR-338-3p | CACNB4 | 0.26 | 0.82352 | 0.17 | 0.63328 | PITA; miRanda; miRNATAP | -0.3 | 0.00016 | NA | |
82 | hsa-miR-338-3p | CADM1 | 0.26 | 0.82352 | 0.14 | 0.76681 | PITA; miRanda | -0.23 | 0.00461 | NA | |
83 | hsa-miR-107 | CADM2 | -0.07 | 0.96422 | 0.28 | 0.70913 | miRanda | -0.97 | 1.0E-5 | NA | |
84 | hsa-miR-338-3p | CADM2 | 0.26 | 0.82352 | 0.28 | 0.70913 | miRanda; miRNATAP | -0.26 | 0.00812 | NA | |
85 | hsa-miR-107 | CADM3 | -0.07 | 0.96422 | -0.11 | 0.84236 | miRanda | -1.51 | 0 | NA | |
86 | hsa-miR-338-3p | CADM3 | 0.26 | 0.82352 | -0.11 | 0.84236 | miRanda | -0.29 | 0.03788 | NA | |
87 | hsa-miR-107 | CALCA | -0.07 | 0.96422 | 0.95 | 0.16171 | miRanda | -1.29 | 0.00019 | NA | |
88 | hsa-miR-107 | CALD1 | -0.07 | 0.96422 | 0.1 | 0.9298 | miRanda | -0.66 | 1.0E-5 | NA | |
89 | hsa-miR-338-3p | CALD1 | 0.26 | 0.82352 | 0.1 | 0.9298 | miRanda | -0.22 | 0.00082 | NA | |
90 | hsa-miR-107 | CAP2 | -0.07 | 0.96422 | 0.28 | 0.45438 | miRanda | -0.58 | 4.0E-5 | NA | |
91 | hsa-miR-338-3p | CAV1 | 0.26 | 0.82352 | 0.05 | 0.95242 | miRanda | -0.21 | 0.00012 | NA | |
92 | hsa-miR-338-3p | CBX6 | 0.26 | 0.82352 | -0.23 | 0.66338 | mirMAP | -0.28 | 6.0E-5 | NA | |
93 | hsa-miR-338-3p | CCBE1 | 0.26 | 0.82352 | -0.28 | 0.58179 | miRanda | -0.35 | 0.00191 | NA | |
94 | hsa-miR-107 | CCDC50 | -0.07 | 0.96422 | 0.08 | 0.92311 | MirTarget; miRanda; miRNATAP | -0.12 | 0.01008 | NA | |
95 | hsa-miR-107 | CCDC85A | -0.07 | 0.96422 | -0.12 | 0.7313 | miRanda | -0.5 | 0.00318 | NA | |
96 | hsa-miR-338-3p | CCL21 | 0.26 | 0.82352 | -0.38 | 0.60205 | miRNATAP | -0.3 | 0.0398 | NA | |
97 | hsa-miR-338-3p | CD200 | 0.26 | 0.82352 | -0.12 | 0.79242 | miRanda | -0.14 | 0.03343 | NA | |
98 | hsa-miR-107 | CD34 | -0.07 | 0.96422 | 0.15 | 0.83407 | miRanda | -0.21 | 0.02322 | NA | |
99 | hsa-miR-338-3p | CDC14A | 0.26 | 0.82352 | -0.08 | 0.8497 | miRanda | -0.12 | 0.00053 | NA | |
100 | hsa-miR-338-3p | CDH5 | 0.26 | 0.82352 | 0.01 | 0.99191 | miRanda | -0.12 | 0.01545 | NA | |
101 | hsa-miR-107 | CDK14 | -0.07 | 0.96422 | 0.01 | 0.97664 | MirTarget; miRanda; miRNATAP | -0.53 | 0.00109 | NA | |
102 | hsa-miR-107 | CDKN1C | -0.07 | 0.96422 | -0.16 | 0.74975 | miRanda | -0.48 | 0.00088 | NA | |
103 | hsa-miR-338-3p | CENPBD1 | 0.26 | 0.82352 | 0.13 | 0.79823 | miRanda | -0.12 | 0.00012 | NA | |
104 | hsa-miR-107 | CEP68 | -0.07 | 0.96422 | -0.12 | 0.86579 | miRanda | -0.26 | 6.0E-5 | NA | |
105 | hsa-miR-107 | CFDP1 | -0.07 | 0.96422 | 0.02 | 0.98297 | miRanda | -0.11 | 0.04929 | NA | |
106 | hsa-miR-107 | CHD6 | -0.07 | 0.96422 | -0.32 | 0.69558 | PITA; miRanda | -0.27 | 0.00054 | NA | |
107 | hsa-miR-107 | CHIC1 | -0.07 | 0.96422 | -0.11 | 0.83368 | PITA; miRanda; miRNATAP | -0.22 | 0.01715 | NA | |
108 | hsa-miR-338-3p | CHL1 | 0.26 | 0.82352 | -0.21 | 0.62739 | MirTarget; PITA; miRanda | -0.25 | 0.02306 | NA | |
109 | hsa-miR-107 | CHODL | -0.07 | 0.96422 | -0.08 | 0.88134 | miRanda | -1.1 | 0 | NA | |
110 | hsa-miR-338-3p | CHODL | 0.26 | 0.82352 | -0.08 | 0.88134 | miRanda | -0.43 | 4.0E-5 | NA | |
111 | hsa-miR-338-3p | CHST10 | 0.26 | 0.82352 | 0.19 | 0.53596 | miRanda | -0.21 | 0.00191 | NA | |
112 | hsa-miR-107 | CIRBP | -0.07 | 0.96422 | -0.07 | 0.94837 | mirMAP | -0.17 | 0.00356 | NA | |
113 | hsa-miR-107 | CKB | -0.07 | 0.96422 | -0.7 | 0.54933 | miRanda | -0.52 | 0.02288 | NA | |
114 | hsa-miR-107 | CLIP1 | -0.07 | 0.96422 | -0 | 0.99869 | MirTarget; miRanda; miRNATAP | -0.13 | 0.00532 | NA | |
115 | hsa-miR-107 | CLIP4 | -0.07 | 0.96422 | 0.12 | 0.75478 | miRanda | -0.63 | 0.00036 | NA | |
116 | hsa-miR-107 | CLU | -0.07 | 0.96422 | -0.34 | 0.68818 | miRanda | -0.88 | 0 | NA | |
117 | hsa-miR-107 | CNIH3 | -0.07 | 0.96422 | -0.18 | 0.5887 | miRanda; miRNATAP | -0.65 | 9.0E-5 | NA | |
118 | hsa-miR-107 | CNNM2 | -0.07 | 0.96422 | -0.13 | 0.79721 | MirTarget; PITA; miRanda; miRNATAP | -0.12 | 0.03281 | NA | |
119 | hsa-miR-338-3p | CNR1 | 0.26 | 0.82352 | -0.66 | 0.19872 | PITA; miRanda | -0.26 | 0.02962 | NA | |
120 | hsa-miR-338-3p | CNTLN | 0.26 | 0.82352 | -0.05 | 0.8892 | miRanda | -0.23 | 0.00016 | NA | |
121 | hsa-miR-338-3p | CNTN2 | 0.26 | 0.82352 | -0.4 | 0.51237 | mirMAP | -0.28 | 0.00767 | NA | |
122 | hsa-miR-107 | CNTN3 | -0.07 | 0.96422 | 0.46 | 0.37052 | miRanda | -0.64 | 0.02536 | NA | |
123 | hsa-miR-107 | CNTN4 | -0.07 | 0.96422 | -0.23 | 0.49815 | miRanda | -0.55 | 0.00274 | NA | |
124 | hsa-miR-107 | CNTNAP1 | -0.07 | 0.96422 | 0.03 | 0.94977 | MirTarget; PITA; miRanda; miRNATAP | -0.85 | 0 | NA | |
125 | hsa-miR-107 | COL12A1 | -0.07 | 0.96422 | 0.05 | 0.9648 | miRanda | -0.32 | 0.04937 | NA | |
126 | hsa-miR-107 | COL1A1 | -0.07 | 0.96422 | 0.38 | 0.81061 | PITA; miRanda | -0.42 | 0.0255 | NA | |
127 | hsa-miR-107 | COL24A1 | -0.07 | 0.96422 | 0.07 | 0.84765 | miRanda | -0.47 | 0.02668 | NA | |
128 | hsa-miR-107 | COL3A1 | -0.07 | 0.96422 | 0.23 | 0.88029 | miRanda | -0.44 | 0.01421 | NA | |
129 | hsa-miR-107 | COL5A1 | -0.07 | 0.96422 | 0.21 | 0.85755 | miRanda | -0.34 | 0.02714 | NA | |
130 | hsa-miR-107 | COL9A1 | -0.07 | 0.96422 | 0.08 | 0.88768 | miRanda | -0.82 | 0.01147 | NA | |
131 | hsa-miR-107 | COLQ | -0.07 | 0.96422 | 0.31 | 0.14108 | miRanda | -0.46 | 5.0E-5 | NA | |
132 | hsa-miR-107 | CORIN | -0.07 | 0.96422 | 0.18 | 0.64084 | miRanda | -0.62 | 0.00473 | NA | |
133 | hsa-miR-107 | CORO2B | -0.07 | 0.96422 | 0.03 | 0.92615 | MirTarget; PITA; miRanda; miRNATAP | -0.52 | 0.00459 | NA | |
134 | hsa-miR-107 | CPA6 | -0.07 | 0.96422 | 0.24 | 0.70611 | miRanda | -0.84 | 0.0223 | NA | |
135 | hsa-miR-338-3p | CPLX2 | 0.26 | 0.82352 | -0.44 | 0.40994 | PITA; mirMAP | -0.33 | 0.01349 | NA | |
136 | hsa-miR-338-3p | CRMP1 | 0.26 | 0.82352 | -0.12 | 0.7553 | miRanda | -0.17 | 0.00638 | NA | |
137 | hsa-miR-338-3p | CRYM | 0.26 | 0.82352 | -0.07 | 0.87009 | miRanda | -0.19 | 0.02278 | NA | |
138 | hsa-miR-107 | CSRP1 | -0.07 | 0.96422 | 0.21 | 0.8493 | miRanda | -0.48 | 0 | NA | |
139 | hsa-miR-338-3p | DACT3 | 0.26 | 0.82352 | 0.24 | 0.54313 | miRanda | -0.23 | 0.00186 | NA | |
140 | hsa-miR-107 | DBNDD2 | -0.07 | 0.96422 | 0.07 | 0.94458 | miRanda | -0.15 | 0.03911 | NA | |
141 | hsa-miR-107 | DCLK1 | -0.07 | 0.96422 | -0.42 | 0.28986 | miRNATAP | -0.83 | 0.00029 | NA | |
142 | hsa-miR-338-3p | DCLK2 | 0.26 | 0.82352 | 0.06 | 0.82629 | miRanda | -0.16 | 0.01167 | NA | |
143 | hsa-miR-107 | DDAH2 | -0.07 | 0.96422 | 0.17 | 0.8582 | miRanda | -0.27 | 0.0051 | NA | |
144 | hsa-miR-338-3p | DDIT4L | 0.26 | 0.82352 | 0.41 | 0.36934 | miRanda | -0.32 | 0.00233 | NA | |
145 | hsa-miR-338-3p | DENND5A | 0.26 | 0.82352 | -0.02 | 0.97749 | miRanda | -0.2 | 0 | NA | |
146 | hsa-miR-338-3p | DES | 0.26 | 0.82352 | -0.26 | 0.79221 | PITA; miRanda | -0.66 | 4.0E-5 | NA | |
147 | hsa-miR-338-3p | DGKB | 0.26 | 0.82352 | -0.09 | 0.88559 | MirTarget; PITA; miRanda | -0.3 | 0.01219 | NA | |
148 | hsa-miR-107 | DHRS12 | -0.07 | 0.96422 | -0 | 0.99413 | miRanda | -0.29 | 0.00272 | NA | |
149 | hsa-miR-107 | DIP2C | -0.07 | 0.96422 | -0.09 | 0.87596 | miRanda | -0.56 | 0 | NA | |
150 | hsa-miR-107 | DKK1 | -0.07 | 0.96422 | 0.2 | 0.73405 | miRanda | -1.07 | 0.00153 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | CARDIOVASCULAR SYSTEM DEVELOPMENT | 88 | 788 | 3.979e-23 | 9.258e-20 |
2 | CIRCULATORY SYSTEM DEVELOPMENT | 88 | 788 | 3.979e-23 | 9.258e-20 |
3 | NEUROGENESIS | 117 | 1402 | 6.884e-20 | 1.068e-16 |
4 | REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 128 | 1672 | 1.293e-18 | 1.504e-15 |
5 | CELL DEVELOPMENT | 114 | 1426 | 5.949e-18 | 5.536e-15 |
6 | CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 61 | 513 | 1.475e-17 | 1.144e-14 |
7 | HEART DEVELOPMENT | 56 | 466 | 2.089e-16 | 1.388e-13 |
8 | REGULATION OF CELL DIFFERENTIATION | 113 | 1492 | 4.43e-16 | 2.576e-13 |
9 | BIOLOGICAL ADHESION | 88 | 1032 | 1.411e-15 | 7.297e-13 |
10 | REGULATION OF MEMBRANE POTENTIAL | 45 | 343 | 8.401e-15 | 3.909e-12 |
11 | CELLULAR COMPONENT MORPHOGENESIS | 79 | 900 | 9.871e-15 | 4.175e-12 |
12 | VASCULATURE DEVELOPMENT | 53 | 469 | 1.805e-14 | 6.089e-12 |
13 | NEURON DIFFERENTIATION | 77 | 874 | 1.832e-14 | 6.089e-12 |
14 | REGULATION OF CELL DEVELOPMENT | 75 | 836 | 1.617e-14 | 6.089e-12 |
15 | BEHAVIOR | 55 | 516 | 6.67e-14 | 2.069e-11 |
16 | REGULATION OF BLOOD CIRCULATION | 39 | 295 | 4.215e-13 | 1.226e-10 |
17 | NEURON PROJECTION DEVELOPMENT | 55 | 545 | 6.308e-13 | 1.726e-10 |
18 | TISSUE DEVELOPMENT | 106 | 1518 | 8.222e-13 | 2.125e-10 |
19 | NEURON DEVELOPMENT | 63 | 687 | 9.147e-13 | 2.24e-10 |
20 | POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 87 | 1142 | 1.26e-12 | 2.931e-10 |
21 | REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 66 | 750 | 1.664e-12 | 3.686e-10 |
22 | MOVEMENT OF CELL OR SUBCELLULAR COMPONENT | 93 | 1275 | 2.302e-12 | 4.869e-10 |
23 | TISSUE MORPHOGENESIS | 53 | 533 | 3.006e-12 | 6.082e-10 |
24 | REGULATION OF NEURON DIFFERENTIATION | 54 | 554 | 4.063e-12 | 7.878e-10 |
25 | REGULATION OF HEART CONTRACTION | 32 | 221 | 4.759e-12 | 8.857e-10 |
26 | REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 79 | 1021 | 7.11e-12 | 1.272e-09 |
27 | REGULATION OF SYSTEM PROCESS | 50 | 507 | 1.72e-11 | 2.964e-09 |
28 | SINGLE ORGANISM BEHAVIOR | 42 | 384 | 2.942e-11 | 4.889e-09 |
29 | NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 66 | 801 | 3.064e-11 | 4.916e-09 |
30 | ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 74 | 957 | 3.62e-11 | 5.33e-09 |
31 | CELL CELL SIGNALING | 64 | 767 | 3.665e-11 | 5.33e-09 |
32 | NEURON PROJECTION MORPHOGENESIS | 43 | 402 | 3.523e-11 | 5.33e-09 |
33 | CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 40 | 368 | 1.063e-10 | 1.499e-08 |
34 | CELL PROJECTION ORGANIZATION | 70 | 902 | 1.096e-10 | 1.5e-08 |
35 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 94 | 1395 | 1.38e-10 | 1.834e-08 |
36 | NEGATIVE REGULATION OF CELL DIFFERENTIATION | 54 | 609 | 1.489e-10 | 1.924e-08 |
37 | REGULATION OF CELL PROJECTION ORGANIZATION | 51 | 558 | 1.695e-10 | 2.132e-08 |
38 | REGULATION OF DEVELOPMENTAL GROWTH | 34 | 289 | 3.386e-10 | 4.053e-08 |
39 | ACTION POTENTIAL | 19 | 94 | 3.397e-10 | 4.053e-08 |
40 | COGNITION | 31 | 251 | 6.173e-10 | 7.181e-08 |
41 | POSITIVE REGULATION OF CELL DIFFERENTIATION | 64 | 823 | 6.752e-10 | 7.663e-08 |
42 | MODULATION OF SYNAPTIC TRANSMISSION | 34 | 301 | 9.983e-10 | 1.106e-07 |
43 | MUSCLE STRUCTURE DEVELOPMENT | 42 | 432 | 1.158e-09 | 1.253e-07 |
44 | REGULATION OF ION TRANSPORT | 51 | 592 | 1.339e-09 | 1.416e-07 |
45 | POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 42 | 437 | 1.638e-09 | 1.671e-07 |
46 | REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY | 29 | 232 | 1.67e-09 | 1.671e-07 |
47 | POSITIVE REGULATION OF CELL DEVELOPMENT | 44 | 472 | 1.722e-09 | 1.671e-07 |
48 | CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 27 | 204 | 1.724e-09 | 1.671e-07 |
49 | REGULATION OF NEURON PROJECTION DEVELOPMENT | 40 | 408 | 2.278e-09 | 2.149e-07 |
50 | HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 23 | 153 | 2.309e-09 | 2.149e-07 |
51 | MUSCLE SYSTEM PROCESS | 32 | 282 | 2.778e-09 | 2.535e-07 |
52 | EMBRYO DEVELOPMENT | 66 | 894 | 2.986e-09 | 2.672e-07 |
53 | BLOOD VESSEL MORPHOGENESIS | 37 | 364 | 3.456e-09 | 3.034e-07 |
54 | LOCOMOTION | 76 | 1114 | 5.804e-09 | 5.001e-07 |
55 | MULTICELLULAR ORGANISMAL SIGNALING | 20 | 123 | 6.425e-09 | 5.436e-07 |
56 | CENTRAL NERVOUS SYSTEM DEVELOPMENT | 64 | 872 | 6.61e-09 | 5.492e-07 |
57 | SYNAPTIC SIGNALING | 40 | 424 | 6.854e-09 | 5.595e-07 |
58 | MUSCLE CONTRACTION | 28 | 233 | 7.727e-09 | 6.199e-07 |
59 | REGULATION OF TRANSPORT | 107 | 1804 | 8.83e-09 | 6.963e-07 |
60 | CELL SUBSTRATE ADHESION | 23 | 164 | 9.06e-09 | 7.026e-07 |
61 | ORGAN MORPHOGENESIS | 62 | 841 | 9.793e-09 | 7.47e-07 |
62 | EMBRYONIC MORPHOGENESIS | 46 | 539 | 1.181e-08 | 8.862e-07 |
63 | LOCOMOTORY BEHAVIOR | 24 | 181 | 1.331e-08 | 9.829e-07 |
64 | HEART MORPHOGENESIS | 26 | 212 | 1.734e-08 | 1.261e-06 |
65 | POSITIVE REGULATION OF NEURON DIFFERENTIATION | 32 | 306 | 2.034e-08 | 1.456e-06 |
66 | REGULATION OF TRANSMEMBRANE TRANSPORT | 39 | 426 | 2.415e-08 | 1.702e-06 |
67 | POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 27 | 232 | 2.835e-08 | 1.969e-06 |
68 | HEAD DEVELOPMENT | 54 | 709 | 3.155e-08 | 2.159e-06 |
69 | CELL PART MORPHOGENESIS | 50 | 633 | 3.33e-08 | 2.246e-06 |
70 | MORPHOGENESIS OF AN EPITHELIUM | 37 | 400 | 4.243e-08 | 2.821e-06 |
71 | SKELETAL SYSTEM DEVELOPMENT | 40 | 455 | 4.862e-08 | 3.186e-06 |
72 | POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 31 | 303 | 5.606e-08 | 3.623e-06 |
73 | TUBE DEVELOPMENT | 45 | 552 | 6.635e-08 | 4.172e-06 |
74 | REGULATION OF CELL MORPHOGENESIS | 45 | 552 | 6.635e-08 | 4.172e-06 |
75 | MUSCLE TISSUE DEVELOPMENT | 29 | 275 | 7.813e-08 | 4.847e-06 |
76 | DIVALENT INORGANIC CATION HOMEOSTASIS | 33 | 343 | 9.143e-08 | 5.598e-06 |
77 | METAL ION TRANSPORT | 46 | 582 | 1.177e-07 | 7.11e-06 |
78 | INORGANIC ION TRANSMEMBRANE TRANSPORT | 46 | 583 | 1.237e-07 | 7.379e-06 |
79 | NEURON PROJECTION GUIDANCE | 24 | 205 | 1.488e-07 | 8.762e-06 |
80 | NEGATIVE REGULATION OF CELL DEVELOPMENT | 30 | 303 | 1.887e-07 | 1.098e-05 |
81 | CELL MOTILITY | 58 | 835 | 2.304e-07 | 1.307e-05 |
82 | LOCALIZATION OF CELL | 58 | 835 | 2.304e-07 | 1.307e-05 |
83 | TUBE MORPHOGENESIS | 31 | 323 | 2.368e-07 | 1.327e-05 |
84 | NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 65 | 983 | 2.491e-07 | 1.38e-05 |
85 | ANGIOGENESIS | 29 | 293 | 3.038e-07 | 1.663e-05 |
86 | MUSCLE ORGAN DEVELOPMENT | 28 | 277 | 3.153e-07 | 1.706e-05 |
87 | CELL CELL ADHESION | 46 | 608 | 4.126e-07 | 2.207e-05 |
88 | REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 23 | 203 | 4.859e-07 | 2.569e-05 |
89 | CALCIUM ION TRANSMEMBRANE TRANSPORT | 20 | 159 | 5.091e-07 | 2.662e-05 |
90 | MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL | 10 | 39 | 5.169e-07 | 2.672e-05 |
91 | ION HOMEOSTASIS | 44 | 576 | 5.701e-07 | 2.915e-05 |
92 | MEMBRANE DEPOLARIZATION | 12 | 61 | 8.453e-07 | 4.275e-05 |
93 | REGULATION OF ANATOMICAL STRUCTURE SIZE | 38 | 472 | 9.621e-07 | 4.814e-05 |
94 | NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 26 | 262 | 1.178e-06 | 5.829e-05 |
95 | KIDNEY EPITHELIUM DEVELOPMENT | 17 | 125 | 1.207e-06 | 5.911e-05 |
96 | CYTOSKELETON ORGANIZATION | 56 | 838 | 1.273e-06 | 6.172e-05 |
97 | EPITHELIUM DEVELOPMENT | 61 | 945 | 1.323e-06 | 6.347e-05 |
98 | REGULATION OF SYNAPTIC PLASTICITY | 18 | 140 | 1.361e-06 | 6.462e-05 |
99 | REGULATION OF SYNAPSE ORGANIZATION | 16 | 113 | 1.436e-06 | 6.716e-05 |
100 | HEART VALVE DEVELOPMENT | 9 | 34 | 1.443e-06 | 6.716e-05 |
101 | SYSTEM PROCESS | 98 | 1785 | 1.498e-06 | 6.903e-05 |
102 | POSITIVE REGULATION OF DEVELOPMENTAL GROWTH | 19 | 156 | 1.602e-06 | 7.31e-05 |
103 | NEPHRON DEVELOPMENT | 16 | 115 | 1.821e-06 | 8.228e-05 |
104 | CARDIAC CHAMBER DEVELOPMENT | 18 | 144 | 2.057e-06 | 9.205e-05 |
105 | MUSCLE CELL DIFFERENTIATION | 24 | 237 | 2.112e-06 | 9.36e-05 |
106 | CHEMICAL HOMEOSTASIS | 57 | 874 | 2.18e-06 | 9.571e-05 |
107 | REGULATION OF NEUROTRANSMITTER LEVELS | 21 | 190 | 2.268e-06 | 9.864e-05 |
108 | LEARNING | 17 | 131 | 2.339e-06 | 0.0001008 |
109 | REGULATION OF CELLULAR COMPONENT MOVEMENT | 52 | 771 | 2.366e-06 | 0.000101 |
110 | REGULATION OF METAL ION TRANSPORT | 29 | 325 | 2.542e-06 | 0.0001075 |
111 | REGULATION OF CATION TRANSMEMBRANE TRANSPORT | 22 | 208 | 2.731e-06 | 0.0001145 |
112 | CELL MATRIX ADHESION | 16 | 119 | 2.883e-06 | 0.0001198 |
113 | SPINAL CORD DEVELOPMENT | 15 | 106 | 3.07e-06 | 0.0001253 |
114 | NEPHRON EPITHELIUM DEVELOPMENT | 14 | 93 | 3.097e-06 | 0.0001253 |
115 | POSITIVE REGULATION OF BLOOD CIRCULATION | 14 | 93 | 3.097e-06 | 0.0001253 |
116 | ION TRANSMEMBRANE TRANSPORT | 54 | 822 | 3.292e-06 | 0.0001321 |
117 | INTEGRIN MEDIATED SIGNALING PATHWAY | 13 | 82 | 3.847e-06 | 0.0001517 |
118 | CARDIAC CONDUCTION | 13 | 82 | 3.847e-06 | 0.0001517 |
119 | REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT | 10 | 48 | 4.031e-06 | 0.0001576 |
120 | TAXIS | 36 | 464 | 4.318e-06 | 0.0001674 |
121 | REGULATION OF POTASSIUM ION TRANSPORT | 13 | 83 | 4.422e-06 | 0.00017 |
122 | UROGENITAL SYSTEM DEVELOPMENT | 27 | 299 | 4.491e-06 | 0.0001713 |
123 | APPENDAGE DEVELOPMENT | 19 | 169 | 5.316e-06 | 0.0001995 |
124 | LIMB DEVELOPMENT | 19 | 169 | 5.316e-06 | 0.0001995 |
125 | CATION TRANSPORT | 52 | 796 | 5.888e-06 | 0.0002192 |
126 | REGULATION OF ORGAN GROWTH | 12 | 73 | 6.139e-06 | 0.0002267 |
127 | REGULATION OF HEART RATE | 13 | 86 | 6.624e-06 | 0.0002427 |
128 | OVULATION CYCLE | 15 | 113 | 6.876e-06 | 0.00025 |
129 | RESPONSE TO GROWTH FACTOR | 36 | 475 | 7.284e-06 | 0.0002627 |
130 | MESENCHYME DEVELOPMENT | 20 | 190 | 8.261e-06 | 0.0002934 |
131 | STEM CELL DIFFERENTIATION | 20 | 190 | 8.261e-06 | 0.0002934 |
132 | NEGATIVE REGULATION OF NEURON DIFFERENTIATION | 20 | 191 | 8.938e-06 | 0.0003151 |
133 | SYNAPSE ORGANIZATION | 17 | 145 | 9.411e-06 | 0.0003268 |
134 | CIRCULATORY SYSTEM PROCESS | 30 | 366 | 9.395e-06 | 0.0003268 |
135 | REGULATION OF NEUROTRANSMITTER TRANSPORT | 11 | 64 | 9.592e-06 | 0.0003306 |
136 | REGULATION OF ACTIN FILAMENT BASED PROCESS | 27 | 312 | 9.844e-06 | 0.0003343 |
137 | NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 46 | 684 | 9.841e-06 | 0.0003343 |
138 | RESPONSE TO ENDOGENOUS STIMULUS | 80 | 1450 | 1.293e-05 | 0.0004359 |
139 | REGULATION OF CARDIAC CONDUCTION | 11 | 66 | 1.302e-05 | 0.000436 |
140 | MESENCHYMAL CELL DIFFERENTIATION | 16 | 134 | 1.357e-05 | 0.0004511 |
141 | ACTIN FILAMENT BASED PROCESS | 34 | 450 | 1.39e-05 | 0.0004587 |
142 | REGULATION OF SYNAPSE ASSEMBLY | 12 | 79 | 1.419e-05 | 0.0004633 |
143 | CELLULAR CHEMICAL HOMEOSTASIS | 40 | 570 | 1.424e-05 | 0.0004633 |
144 | REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL | 10 | 55 | 1.454e-05 | 0.0004689 |
145 | POSTSYNAPTIC MEMBRANE ORGANIZATION | 7 | 25 | 1.461e-05 | 0.0004689 |
146 | REGULATION OF GROWTH | 43 | 633 | 1.508e-05 | 0.0004806 |
147 | CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 18 | 166 | 1.542e-05 | 0.0004882 |
148 | ADULT LOCOMOTORY BEHAVIOR | 12 | 80 | 1.618e-05 | 0.0005088 |
149 | HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 9 | 45 | 1.744e-05 | 0.0005446 |
150 | CELLULAR RESPONSE TO ENDOGENOUS STIMULUS | 60 | 1008 | 1.97e-05 | 0.0006112 |
151 | POTASSIUM ION TRANSPORT | 17 | 154 | 2.091e-05 | 0.0006445 |
152 | POSITIVE REGULATION OF GENE EXPRESSION | 91 | 1733 | 2.162e-05 | 0.0006618 |
153 | CARDIAC MUSCLE TISSUE DEVELOPMENT | 16 | 140 | 2.361e-05 | 0.0007179 |
154 | ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 45 | 689 | 2.532e-05 | 0.000765 |
155 | NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH | 12 | 84 | 2.681e-05 | 0.0008048 |
156 | CALCIUM ION TRANSPORT | 21 | 223 | 2.73e-05 | 0.0008143 |
157 | CARDIAC MUSCLE CELL ACTION POTENTIAL | 8 | 37 | 2.82e-05 | 0.0008356 |
158 | CARDIAC SEPTUM DEVELOPMENT | 12 | 85 | 3.026e-05 | 0.0008897 |
159 | REGULATION OF ORGAN MORPHOGENESIS | 22 | 242 | 3.052e-05 | 0.0008897 |
160 | REGULATION OF STEM CELL DIFFERENTIATION | 14 | 113 | 3.059e-05 | 0.0008897 |
161 | STRIATED MUSCLE CONTRACTION | 13 | 99 | 3.138e-05 | 0.000907 |
162 | SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 8 | 38 | 3.466e-05 | 0.0009954 |
163 | NEGATIVE REGULATION OF LOCOMOTION | 23 | 263 | 3.745e-05 | 0.001069 |
164 | EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING | 38 | 554 | 3.823e-05 | 0.001078 |
165 | CONNECTIVE TISSUE DEVELOPMENT | 19 | 194 | 3.805e-05 | 0.001078 |
166 | REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 27 | 337 | 3.872e-05 | 0.001085 |
167 | AXONAL FASCICULATION | 6 | 20 | 3.959e-05 | 0.001103 |
168 | REGULATION OF CELLULAR COMPONENT BIOGENESIS | 48 | 767 | 4.027e-05 | 0.001115 |
169 | FOREBRAIN DEVELOPMENT | 28 | 357 | 4.089e-05 | 0.001126 |
170 | PROTEIN PHOSPHORYLATION | 56 | 944 | 4.121e-05 | 0.001128 |
171 | CARTILAGE DEVELOPMENT | 16 | 147 | 4.32e-05 | 0.001169 |
172 | EMBRYONIC HEART TUBE MORPHOGENESIS | 10 | 62 | 4.311e-05 | 0.001169 |
173 | POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 65 | 1152 | 4.567e-05 | 0.001228 |
174 | RESPIRATORY SYSTEM DEVELOPMENT | 19 | 197 | 4.698e-05 | 0.001256 |
175 | REGULATION OF NEUROTRANSMITTER SECRETION | 9 | 51 | 4.988e-05 | 0.001324 |
176 | REGULATION OF TRANSPORTER ACTIVITY | 19 | 198 | 5.035e-05 | 0.001324 |
177 | DIVALENT INORGANIC CATION TRANSPORT | 23 | 268 | 5.02e-05 | 0.001324 |
178 | CARDIAC CHAMBER MORPHOGENESIS | 13 | 104 | 5.311e-05 | 0.001388 |
179 | MORPHOGENESIS OF A BRANCHING STRUCTURE | 17 | 167 | 5.925e-05 | 0.00154 |
180 | RENAL TUBULE DEVELOPMENT | 11 | 78 | 6.514e-05 | 0.001674 |
181 | CARDIAC VENTRICLE DEVELOPMENT | 13 | 106 | 6.492e-05 | 0.001674 |
182 | EMBRYONIC ORGAN DEVELOPMENT | 30 | 406 | 6.622e-05 | 0.001693 |
183 | CYTOSOLIC CALCIUM ION TRANSPORT | 9 | 53 | 6.838e-05 | 0.001739 |
184 | REGULATION OF HEART GROWTH | 8 | 42 | 7.417e-05 | 0.001876 |
185 | TRANSMISSION OF NERVE IMPULSE | 9 | 54 | 7.961e-05 | 0.002002 |
186 | NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT | 7 | 32 | 8.311e-05 | 0.002079 |
187 | BONE DEVELOPMENT | 16 | 156 | 8.86e-05 | 0.002205 |
188 | STRIATED MUSCLE CELL DIFFERENTIATION | 17 | 173 | 9.211e-05 | 0.002268 |
189 | REGULATION OF CELL SUBSTRATE ADHESION | 17 | 173 | 9.211e-05 | 0.002268 |
190 | REGULATION OF N METHYL D ASPARTATE SELECTIVE GLUTAMATE RECEPTOR ACTIVITY | 5 | 15 | 0.0001026 | 0.002514 |
191 | KIDNEY MORPHOGENESIS | 11 | 82 | 0.0001037 | 0.002525 |
192 | NEGATIVE REGULATION OF TRANSPORT | 32 | 458 | 0.0001099 | 0.002664 |
193 | PATTERN SPECIFICATION PROCESS | 30 | 418 | 0.0001116 | 0.002676 |
194 | RESPONSE TO MECHANICAL STIMULUS | 19 | 210 | 0.000111 | 0.002676 |
195 | NEUROMUSCULAR PROCESS | 12 | 97 | 0.0001131 | 0.002698 |
196 | DEVELOPMENTAL MATURATION | 18 | 193 | 0.0001136 | 0.002698 |
197 | POSITIVE REGULATION OF LOCOMOTION | 30 | 420 | 0.0001214 | 0.002865 |
198 | NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION | 15 | 144 | 0.0001225 | 0.002865 |
199 | CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 6 | 24 | 0.0001223 | 0.002865 |
200 | REGULATION OF GTPASE ACTIVITY | 42 | 673 | 0.0001292 | 0.002978 |
201 | EXTRACELLULAR STRUCTURE ORGANIZATION | 24 | 304 | 0.0001287 | 0.002978 |
202 | POSITIVE REGULATION OF OSSIFICATION | 11 | 84 | 0.0001293 | 0.002978 |
203 | CELLULAR HOMEOSTASIS | 42 | 676 | 0.0001423 | 0.003261 |
204 | REGULATION OF CHONDROCYTE DIFFERENTIATION | 8 | 46 | 0.0001454 | 0.003269 |
205 | HEART PROCESS | 11 | 85 | 0.000144 | 0.003269 |
206 | PROTEIN LOCALIZATION TO SYNAPSE | 5 | 16 | 0.0001451 | 0.003269 |
207 | ATRIOVENTRICULAR VALVE MORPHOGENESIS | 5 | 16 | 0.0001451 | 0.003269 |
208 | STARTLE RESPONSE | 6 | 25 | 0.0001564 | 0.003498 |
209 | PRESYNAPTIC PROCESS INVOLVED IN SYNAPTIC TRANSMISSION | 13 | 116 | 0.0001645 | 0.003662 |
210 | DIGESTIVE SYSTEM DEVELOPMENT | 15 | 148 | 0.0001665 | 0.00369 |
211 | EMBRYONIC HEART TUBE DEVELOPMENT | 10 | 73 | 0.000178 | 0.003925 |
212 | REGULATION OF RECEPTOR ACTIVITY | 13 | 117 | 0.0001794 | 0.003937 |
213 | REGIONALIZATION | 24 | 311 | 0.0001817 | 0.003968 |
214 | REGULATION OF MUSCLE TISSUE DEVELOPMENT | 12 | 103 | 0.0002014 | 0.004333 |
215 | ACTIN MEDIATED CELL CONTRACTION | 10 | 74 | 0.0001996 | 0.004333 |
216 | POSITIVE REGULATION OF GROWTH | 20 | 238 | 0.0002021 | 0.004333 |
217 | REGULATION OF MUSCLE ORGAN DEVELOPMENT | 12 | 103 | 0.0002014 | 0.004333 |
218 | RESPONSE TO EXTERNAL STIMULUS | 90 | 1821 | 0.0002102 | 0.004465 |
219 | REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 9 | 61 | 0.00021 | 0.004465 |
220 | ADULT BEHAVIOR | 14 | 135 | 0.000214 | 0.004506 |
221 | TRANSMEMBRANE TRANSPORT | 60 | 1098 | 0.000214 | 0.004506 |
222 | MONOVALENT INORGANIC CATION TRANSPORT | 30 | 435 | 0.0002235 | 0.004684 |
223 | CARDIAC SEPTUM MORPHOGENESIS | 8 | 49 | 0.0002297 | 0.004793 |
224 | POSITIVE REGULATION OF CELL COMMUNICATION | 78 | 1532 | 0.0002345 | 0.004872 |
225 | POSITIVE REGULATION OF HEART GROWTH | 6 | 27 | 0.0002466 | 0.0051 |
226 | SKELETAL MUSCLE ORGAN DEVELOPMENT | 14 | 137 | 0.0002496 | 0.00514 |
227 | COLLAGEN FIBRIL ORGANIZATION | 7 | 38 | 0.0002609 | 0.005302 |
228 | POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 7 | 38 | 0.0002609 | 0.005302 |
229 | POSITIVE REGULATION OF ORGAN GROWTH | 7 | 38 | 0.0002609 | 0.005302 |
230 | REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 8 | 50 | 0.0002654 | 0.005369 |
231 | REGULATION OF CYTOSKELETON ORGANIZATION | 33 | 502 | 0.0002668 | 0.005374 |
232 | POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 5 | 18 | 0.000269 | 0.005387 |
233 | REGULATION OF CARTILAGE DEVELOPMENT | 9 | 63 | 0.0002697 | 0.005387 |
234 | NEUROTRANSMITTER TRANSPORT | 15 | 155 | 0.0002769 | 0.005506 |
235 | NEGATIVE REGULATION OF PROTEIN COMPLEX ASSEMBLY | 12 | 107 | 0.0002886 | 0.005714 |
236 | SIGNAL RELEASE | 16 | 173 | 0.0002948 | 0.005812 |
237 | NEURONAL ACTION POTENTIAL | 6 | 28 | 0.0003049 | 0.005986 |
238 | LONG TERM SYNAPTIC POTENTIATION | 7 | 39 | 0.0003088 | 0.006011 |
239 | NEGATIVE CHEMOTAXIS | 7 | 39 | 0.0003088 | 0.006011 |
240 | ACTIN FILAMENT BASED MOVEMENT | 11 | 93 | 0.0003219 | 0.00624 |
241 | REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 19 | 229 | 0.0003393 | 0.00655 |
242 | DENDRITE DEVELOPMENT | 10 | 79 | 0.0003437 | 0.006608 |
243 | ION TRANSPORT | 66 | 1262 | 0.000353 | 0.006684 |
244 | REGULATION OF ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLE PROPIONATE SELECTIVE GLUTAMATE RECEPTOR ACTIVITY | 5 | 19 | 0.0003548 | 0.006684 |
245 | REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION | 5 | 19 | 0.0003548 | 0.006684 |
246 | ATRIOVENTRICULAR VALVE DEVELOPMENT | 5 | 19 | 0.0003548 | 0.006684 |
247 | ESTROUS CYCLE | 5 | 19 | 0.0003548 | 0.006684 |
248 | NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 4 | 11 | 0.0003652 | 0.006852 |
249 | NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 70 | 1360 | 0.0003667 | 0.006852 |
250 | REGULATION OF THE FORCE OF HEART CONTRACTION | 6 | 29 | 0.0003734 | 0.006868 |
251 | CARDIAC MUSCLE CELL CONTRACTION | 6 | 29 | 0.0003734 | 0.006868 |
252 | NEURON MIGRATION | 12 | 110 | 0.0003733 | 0.006868 |
253 | POSITIVE REGULATION OF SYNAPTIC TRANSMISSION | 12 | 110 | 0.0003733 | 0.006868 |
254 | MULTI MULTICELLULAR ORGANISM PROCESS | 18 | 213 | 0.0003862 | 0.007075 |
255 | SECOND MESSENGER MEDIATED SIGNALING | 15 | 160 | 0.00039 | 0.007117 |
256 | REGULATION OF G PROTEIN COUPLED RECEPTOR PROTEIN SIGNALING PATHWAY | 13 | 127 | 0.0004042 | 0.007347 |
257 | REGULATION OF OSSIFICATION | 16 | 178 | 0.0004059 | 0.00735 |
258 | RESPONSE TO TRANSFORMING GROWTH FACTOR BETA | 14 | 144 | 0.0004175 | 0.007486 |
259 | GROWTH | 28 | 410 | 0.0004183 | 0.007486 |
260 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 87 | 1784 | 0.0004163 | 0.007486 |
261 | NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR PROTEIN SIGNALING PATHWAY | 7 | 41 | 0.0004254 | 0.007556 |
262 | RECEPTOR CLUSTERING | 7 | 41 | 0.0004254 | 0.007556 |
263 | REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 9 | 67 | 0.0004318 | 0.00764 |
264 | RESPONSE TO OXYGEN LEVELS | 23 | 311 | 0.0004497 | 0.007926 |
265 | MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 6 | 30 | 0.0004535 | 0.007932 |
266 | REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY | 6 | 30 | 0.0004535 | 0.007932 |
267 | VENTRICULAR SEPTUM DEVELOPMENT | 8 | 54 | 0.0004564 | 0.007953 |
268 | VASCULAR PROCESS IN CIRCULATORY SYSTEM | 15 | 163 | 0.0004754 | 0.008253 |
269 | REGULATION OF NEUROLOGICAL SYSTEM PROCESS | 9 | 68 | 0.0004829 | 0.008353 |
270 | REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 19 | 236 | 0.0004934 | 0.008449 |
271 | RESPONSE TO WOUNDING | 35 | 563 | 0.0004955 | 0.008449 |
272 | DENDRITE MORPHOGENESIS | 7 | 42 | 0.0004957 | 0.008449 |
273 | DEVELOPMENTAL GROWTH | 24 | 333 | 0.0004949 | 0.008449 |
274 | REGULATION OF HYDROLASE ACTIVITY | 68 | 1327 | 0.0005024 | 0.008532 |
275 | MEMORY | 11 | 98 | 0.0005075 | 0.008564 |
276 | INTRACELLULAR SIGNAL TRANSDUCTION | 78 | 1572 | 0.0005094 | 0.008564 |
277 | RESPONSE TO ESTROGEN | 18 | 218 | 0.0005098 | 0.008564 |
278 | NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 4 | 12 | 0.000533 | 0.008858 |
279 | NEGATIVE REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS | 4 | 12 | 0.000533 | 0.008858 |
280 | CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 89 | 1848 | 0.0005321 | 0.008858 |
281 | BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE | 13 | 131 | 0.0005452 | 0.009029 |
282 | RESPONSE TO OXYGEN CONTAINING COMPOUND | 70 | 1381 | 0.0005607 | 0.009251 |
283 | EPITHELIAL TO MESENCHYMAL TRANSITION | 8 | 56 | 0.0005869 | 0.009616 |
284 | POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 5 | 21 | 0.0005868 | 0.009616 |
285 | RHYTHMIC PROCESS | 22 | 298 | 0.0006072 | 0.009913 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | CATION CHANNEL ACTIVITY | 36 | 298 | 4.774e-11 | 4.435e-08 |
2 | METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 42 | 417 | 3.936e-10 | 1.828e-07 |
3 | GATED CHANNEL ACTIVITY | 33 | 325 | 2.513e-08 | 6.642e-06 |
4 | PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 41 | 464 | 2.86e-08 | 6.642e-06 |
5 | VOLTAGE GATED ION CHANNEL ACTIVITY | 23 | 190 | 1.465e-07 | 2.723e-05 |
6 | CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 18 | 128 | 3.548e-07 | 4.709e-05 |
7 | INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 42 | 527 | 3.379e-07 | 4.709e-05 |
8 | ION CHANNEL BINDING | 16 | 111 | 1.125e-06 | 0.0001307 |
9 | CYTOSKELETAL PROTEIN BINDING | 55 | 819 | 1.368e-06 | 0.0001412 |
10 | ACTIN BINDING | 33 | 393 | 2.013e-06 | 0.000187 |
11 | CELL ADHESION MOLECULE BINDING | 20 | 186 | 5.99e-06 | 0.0005059 |
12 | CALCIUM ION BINDING | 47 | 697 | 7.34e-06 | 0.0005179 |
13 | GLYCOSAMINOGLYCAN BINDING | 21 | 205 | 7.567e-06 | 0.0005179 |
14 | POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 17 | 143 | 7.805e-06 | 0.0005179 |
15 | CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 43 | 622 | 9.846e-06 | 0.0005897 |
16 | CHANNEL REGULATOR ACTIVITY | 16 | 131 | 1.016e-05 | 0.0005897 |
17 | MOLECULAR FUNCTION REGULATOR | 76 | 1353 | 1.169e-05 | 0.0006391 |
18 | VOLTAGE GATED CATION CHANNEL ACTIVITY | 16 | 134 | 1.357e-05 | 0.0007006 |
19 | POTASSIUM CHANNEL ACTIVITY | 15 | 120 | 1.442e-05 | 0.0007051 |
20 | DIVALENT INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 18 | 167 | 1.675e-05 | 0.0007779 |
21 | SULFUR COMPOUND BINDING | 22 | 234 | 1.816e-05 | 0.0008032 |
22 | HEPARIN BINDING | 17 | 157 | 2.689e-05 | 0.001136 |
23 | CALMODULIN BINDING | 18 | 179 | 4.267e-05 | 0.001652 |
24 | RECEPTOR BINDING | 79 | 1476 | 4.204e-05 | 0.001652 |
25 | POTASSIUM CHANNEL REGULATOR ACTIVITY | 8 | 46 | 0.0001454 | 0.005404 |
26 | SH3 DOMAIN BINDING | 13 | 116 | 0.0001645 | 0.00566 |
27 | TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 25 | 328 | 0.000163 | 0.00566 |
28 | PROTEIN COMPLEX BINDING | 53 | 935 | 0.0002083 | 0.006912 |
29 | VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY | 11 | 89 | 0.000218 | 0.006984 |
30 | EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT | 10 | 76 | 0.0002495 | 0.007297 |
31 | NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY | 64 | 1199 | 0.0002513 | 0.007297 |
32 | CHEMOREPELLENT ACTIVITY | 6 | 27 | 0.0002466 | 0.007297 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | NEURON PROJECTION | 92 | 942 | 4.256e-20 | 2.485e-17 |
2 | NEURON PART | 105 | 1265 | 1.113e-17 | 3.25e-15 |
3 | CELL PROJECTION | 129 | 1786 | 1.045e-16 | 2.034e-14 |
4 | SYNAPSE | 73 | 754 | 7.188e-16 | 1.049e-13 |
5 | AXON | 48 | 418 | 1.785e-13 | 2.084e-11 |
6 | CATION CHANNEL COMPLEX | 29 | 167 | 4.583e-13 | 4.46e-11 |
7 | SYNAPSE PART | 59 | 610 | 5.412e-13 | 4.515e-11 |
8 | CELL PROJECTION PART | 76 | 946 | 2.988e-12 | 2.181e-10 |
9 | SOMATODENDRITIC COMPARTMENT | 57 | 650 | 6.892e-11 | 4.472e-09 |
10 | TRANSPORTER COMPLEX | 37 | 321 | 1.01e-10 | 5.896e-09 |
11 | AXON PART | 29 | 219 | 4.25e-10 | 2.257e-08 |
12 | CELL JUNCTION | 79 | 1151 | 2.141e-09 | 9.619e-08 |
13 | PLASMA MEMBRANE PROTEIN COMPLEX | 46 | 510 | 2.096e-09 | 9.619e-08 |
14 | POTASSIUM CHANNEL COMPLEX | 17 | 90 | 8.568e-09 | 3.574e-07 |
15 | POSTSYNAPSE | 35 | 378 | 9.627e-08 | 3.748e-06 |
16 | DENDRITE | 39 | 451 | 1.107e-07 | 4.04e-06 |
17 | PRESYNAPSE | 29 | 283 | 1.452e-07 | 4.987e-06 |
18 | EXTRACELLULAR MATRIX | 37 | 426 | 2.106e-07 | 6.706e-06 |
19 | PROTEINACEOUS EXTRACELLULAR MATRIX | 33 | 356 | 2.182e-07 | 6.706e-06 |
20 | INTRINSIC COMPONENT OF PLASMA MEMBRANE | 92 | 1649 | 1.684e-06 | 4.916e-05 |
21 | SARCOLEMMA | 16 | 125 | 5.526e-06 | 0.0001537 |
22 | PLASMA MEMBRANE REGION | 58 | 929 | 6.752e-06 | 0.0001714 |
23 | PLASMA MEMBRANE RAFT | 13 | 86 | 6.624e-06 | 0.0001714 |
24 | NEURON PROJECTION TERMINUS | 16 | 129 | 8.328e-06 | 0.0001936 |
25 | CELL CELL JUNCTION | 31 | 383 | 8.619e-06 | 0.0001936 |
26 | MEMBRANE REGION | 67 | 1134 | 8.061e-06 | 0.0001936 |
27 | NEURONAL POSTSYNAPTIC DENSITY | 10 | 53 | 1.03e-05 | 0.0002229 |
28 | CONTRACTILE FIBER | 21 | 211 | 1.182e-05 | 0.0002465 |
29 | SITE OF POLARIZED GROWTH | 17 | 149 | 1.354e-05 | 0.0002726 |
30 | EXCITATORY SYNAPSE | 20 | 197 | 1.416e-05 | 0.0002742 |
31 | MEMBRANE PROTEIN COMPLEX | 61 | 1020 | 1.456e-05 | 0.0002742 |
32 | CELL BODY | 36 | 494 | 1.713e-05 | 0.0003126 |
33 | EXOCYTIC VESICLE | 16 | 142 | 2.818e-05 | 0.0004986 |
34 | CYTOPLASMIC REGION | 24 | 287 | 5.251e-05 | 0.000902 |
35 | TERMINAL BOUTON | 10 | 64 | 5.713e-05 | 0.0009533 |
36 | VOLTAGE GATED SODIUM CHANNEL COMPLEX | 5 | 14 | 7.04e-05 | 0.001118 |
37 | CELL CORTEX | 21 | 238 | 7.084e-05 | 0.001118 |
38 | CELL CELL ADHERENS JUNCTION | 9 | 54 | 7.961e-05 | 0.001223 |
39 | T TUBULE | 8 | 45 | 0.0001238 | 0.001854 |
40 | MAIN AXON | 9 | 58 | 0.0001412 | 0.002062 |
41 | SODIUM CHANNEL COMPLEX | 5 | 17 | 0.0001998 | 0.002846 |
42 | I BAND | 13 | 121 | 0.0002512 | 0.003492 |
43 | EXTRACELLULAR MATRIX COMPONENT | 13 | 125 | 0.0003462 | 0.004702 |
44 | ANCHORING JUNCTION | 32 | 489 | 0.0003558 | 0.004723 |
45 | AXONAL GROWTH CONE | 5 | 20 | 0.0004599 | 0.005969 |
46 | SECRETORY VESICLE | 30 | 461 | 0.000589 | 0.007478 |
47 | SYNAPTIC MEMBRANE | 20 | 261 | 0.0006657 | 0.008271 |
48 | CELL CORTEX PART | 12 | 119 | 0.0007632 | 0.009286 |
49 | CYTOPLASMIC VESICLE PART | 36 | 601 | 0.0008136 | 0.009564 |
50 | COLLAGEN TRIMER | 10 | 88 | 0.0008188 | 0.009564 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | cGMP_PKG_signaling_pathway_hsa04022 | 18 | 163 | 1.199e-05 | 0.0004042 | |
2 | Calcium_signaling_pathway_hsa04020 | 19 | 182 | 1.555e-05 | 0.0004042 | |
3 | Cell_adhesion_molecules_.CAMs._hsa04514 | 16 | 145 | 3.65e-05 | 0.0006327 | |
4 | ECM_receptor_interaction_hsa04512 | 11 | 82 | 0.0001037 | 0.001348 | |
5 | Focal_adhesion_hsa04510 | 18 | 199 | 0.0001674 | 0.001741 | |
6 | cAMP_signaling_pathway_hsa04024 | 17 | 198 | 0.0004626 | 0.00401 | |
7 | Apelin_signaling_pathway_hsa04371 | 13 | 137 | 0.0008335 | 0.006192 | |
8 | Rap1_signaling_pathway_hsa04015 | 15 | 206 | 0.004826 | 0.03045 | |
9 | Regulation_of_actin_cytoskeleton_hsa04810 | 15 | 208 | 0.005271 | 0.03045 | |
10 | PI3K_Akt_signaling_pathway_hsa04151 | 21 | 352 | 0.009708 | 0.05048 | |
11 | Hippo_signaling_pathway_multiple_species_hsa04392 | 4 | 29 | 0.01617 | 0.07644 | |
12 | Hedgehog_signaling_pathway_hsa04340 | 5 | 47 | 0.02141 | 0.09278 | |
13 | MAPK_signaling_pathway_hsa04010 | 17 | 295 | 0.02515 | 0.1006 | |
14 | Adherens_junction_hsa04520 | 6 | 72 | 0.03601 | 0.1338 | |
15 | Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 | 9 | 139 | 0.04871 | 0.1689 | |
16 | TGF_beta_signaling_pathway_hsa04350 | 6 | 84 | 0.06706 | 0.2179 | |
17 | Autophagy_animal_hsa04140 | 8 | 128 | 0.07175 | 0.2195 | |
18 | Hippo_signaling_pathway_hsa04390 | 9 | 154 | 0.08137 | 0.2256 | |
19 | FoxO_signaling_pathway_hsa04068 | 8 | 132 | 0.08243 | 0.2256 | |
20 | Ras_signaling_pathway_hsa04014 | 12 | 232 | 0.1006 | 0.2616 | |
21 | Phospholipase_D_signaling_pathway_hsa04072 | 8 | 146 | 0.1267 | 0.3138 | |
22 | Mitophagy_animal_hsa04137 | 4 | 65 | 0.1809 | 0.4276 | |
23 | Phosphatidylinositol_signaling_system_hsa04070 | 5 | 99 | 0.249 | 0.5572 | |
24 | mTOR_signaling_pathway_hsa04150 | 7 | 151 | 0.2572 | 0.5572 | |
25 | VEGF_signaling_pathway_hsa04370 | 3 | 59 | 0.3266 | 0.6793 | |
26 | Neuroactive_ligand_receptor_interaction_hsa04080 | 11 | 278 | 0.3506 | 0.6797 | |
27 | Gap_junction_hsa04540 | 4 | 88 | 0.3529 | 0.6797 | |
28 | Sphingolipid_signaling_pathway_hsa04071 | 5 | 118 | 0.3759 | 0.6898 | |
29 | AMPK_signaling_pathway_hsa04152 | 5 | 121 | 0.3962 | 0.6898 | |
30 | Ferroptosis_hsa04216 | 2 | 40 | 0.398 | 0.6898 | |
31 | Cellular_senescence_hsa04218 | 6 | 160 | 0.4652 | 0.7803 | |
32 | Tight_junction_hsa04530 | 6 | 170 | 0.524 | 0.8408 | |
33 | ErbB_signaling_pathway_hsa04012 | 3 | 85 | 0.5577 | 0.8408 | |
34 | Wnt_signaling_pathway_hsa04310 | 5 | 146 | 0.5594 | 0.8408 | |
35 | Cytokine_cytokine_receptor_interaction_hsa04060 | 9 | 270 | 0.575 | 0.8408 | |
36 | Endocytosis_hsa04144 | 8 | 244 | 0.5949 | 0.8408 | |
37 | Lysosome_hsa04142 | 4 | 123 | 0.6081 | 0.8408 | |
38 | Cell_cycle_hsa04110 | 4 | 124 | 0.6144 | 0.8408 | |
39 | HIF_1_signaling_pathway_hsa04066 | 3 | 100 | 0.6676 | 0.8721 | |
40 | Phagosome_hsa04145 | 4 | 152 | 0.7658 | 0.9588 | |
41 | Oocyte_meiosis_hsa04114 | 3 | 124 | 0.7994 | 0.9588 | |
42 | NF_kappa_B_signaling_pathway_hsa04064 | 2 | 95 | 0.8394 | 0.9652 | |
43 | Apoptosis_hsa04210 | 3 | 138 | 0.8539 | 0.9652 | |
44 | TNF_signaling_pathway_hsa04668 | 2 | 108 | 0.8871 | 0.9814 | |
45 | Jak_STAT_signaling_pathway_hsa04630 | 2 | 162 | 0.976 | 1 |